| Date | Title | Description |
| 12.04.2025 | TIRmed Pharma's Bold Leap: A New Dawn for Atopic Dermatitis Treatment | In a world where skin conditions often dictate the quality of life, TIRmed Pharma is stepping into the spotlight. The Stockholm-based biotech company has just secured EUR 4.3 million in funding, a financial boost that promises to reshape th... |
| 09.04.2025 | Sciety and Sciety Venture Partners invest EUR 4.3 million in TIRmed Pharma | Sciety and Sciety Venture Partners invest EUR 4.3 million in TIRmed Pharma
Wed, Apr 09, 2025 07:00 CET Report this content
Sciety and Sciety Venture Partners have invested EUR 4.3 million in TIRmed Pharma, a pharmaceutical company developin... |
| 20.12.2024 | Sciety and Sciety Venture Partners invest EUR 3.9 million in PeptiSystems | Sciety and Sciety Venture Partners invest EUR 3.9 million in PeptiSystems
Fri, Dec 20, 2024 07:00 CET Report this content
Sciety and Sciety Venture Partners have invested EUR 3.9 million in PeptiSystems, a biotech company developing advance... |
| 10.04.2024 | Sciety and Sciety Venture Partners invest EUR 1.8 million in Capitainer | Sciety and Sciety Venture Partners invest EUR 1.8 million in Capitainer
Wed, Apr 10, 2024 07:30 CET Report this content
Sciety and Sciety Venture Partners have recently completed an investment of about EUR 1.8 in Capitainer, a Swedish medte... |
| 15.02.2024 | Sciety’s portfolio company Capitainer secures SEK 30 million investment from We Venture Capital, part of the Werfen Group | Sciety’s portfolio company Capitainer secures SEK 30 million investment from We Venture Capital, part of the Werfen Group
Thu, Feb 15, 2024 07:30 CET Report this content
Sciety’s portfolio company Capitainer, a Swedish medtech company that ... |
| 10.11.2023 | Investor event with a focus on opportunities within life science | NEWS. On November 9, 2023, Sciety invited its investor network to an exclusive event on the theme of future scenarios and opportunities within life science. The evening featured a panel discussion on data-driven precision medicine with Tomm... |
| 09.11.2023 | Sciety’s portfolio company Neogap raises SEK 83 million | Sciety’s portfolio company Neogap raises SEK 83 million
Thu, Nov 09, 2023 09:00 CET Report this content
Sciety och Sciety Venture Partners have invested SEK 54 million in Neogap Therapeutics (Neogap), a Swedish clinical-stage biotech compan... |
| 09.11.2023 | Sciety’s portfolio company Neogap raises SEK 83 million | PRESS RELEASE. Sciety och Sciety Venture Partners have invested SEK 54 million in Neogap Therapeutics (Neogap), a Swedish clinical-stage biotech company that develops personalised immunotherapy for cancer treatment with the help of two emer... |
| 02.10.2023 | Sciety’s portfolio company PharmNovo reports positive headline results in clinical phase I study | PRESS RELEASE. Sciety’s portfolio company PharmNovo, a Swedish pharmaceutical company based in Lund, reports positive results in its clinical phase I study of a drug candidate for nerve pain – an area currently lacking safe and effective tr... |
| 31.03.2020 | The Sciety syndicate invests MSEK 9.1 in a cardiovascular diagnostic company | The Sciety investment syndicate recently made an investment of 9.1 million SEK in the company Cavis Technologies, which has developed Wirecath®––a patent-pending product for the diagnosis of coronary heart diseases. The new capital will be ... |
| 24.03.2020 | New diagnostic technology can reduce mortality in one of the world’s most common infectious diseases | Today, Sciety wants to pay attention to World TB Day, which aims to highlight the extensive health, social and economic consequences of tuberculosis. Tuberculosis is a contagious infectious disease that primarily affects the lungs but also ... |
| 23.01.2020 | Sciety invests in cancer diagnostics of the future with Industrifonden | Sciety invests SEK 35 million in the company Elypta, which is developing a new method for early cancer diagnosis. The Sciety network together with the Swedish venture capital fund Industrifonden, Chalmers Ventures and several of the company... |
| 03.12.2019 | Sciety network invests in Predicare, the company that aims to streamline emergency care around the world | The Sciety investment syndicate recently completed an investment of MSEK 9 in Predicare, a company that has developed RETTS––a system used by the majority of Sweden’s emergency units. The new capital will be used to expand in selected Europ... |
| 26.09.2019 | Predicare is growing––new customers in Norway | During September, Predicare finalised an agreement with two new clients in Norway––a hospital and an ambulance services company. Predicare continues to grow rapidly in Norway and their RETTS© system is used by 31 out of 49 hospitals with em... |
| 29.08.2019 | EMPE Diagnostics raises MSEK 9 for launch in India | This week, EMPE Diagnostics completed a new share issue of a total of SEK 9.2 million with Sciety. The company has developed a quick test for tuberculosis and the new capital will support the establishment of operations in India where tuber... |
| 12.06.2019 | The Sciety syndicate invests MSEK 15 in cutting-edge company specializing in DNA sequencing | This week, Single Technologies completed a new share issue of 15 million SEK with Sciety. The company has developed a DNA sequencing solution, which makes it possible to analyse larger amounts of data faster and cheaper than before. The new... |
| 14.05.2019 | Athera Biotechnologies raises MSEK 55 with the help of Sciety | This week, pharmaceutical company Athera Biotechnologies, completed a new share issue of SEK 55 million in which Industrifonden, Östersjöstiftelsen and the Sciety investment syndicate participated. The new capital is to be used for a clinic... |
| 11.02.2019 | Sciety arranges two private placements | Sciety is currently capitalizing a Phase II pharmaceutical company and a DNA sequencing tech company––both via private placements. The companies operate in high growth markets and raise new capital to achieve product development goals that ... |
| 26.11.2018 | New venture at Sciety – develops drugs for diseases caused by high levels of blood lipids | Lipid imbalances does not only cause common diseases such as diabetes and cardiovascular diseases but also various rare diseases. The pharma company Lipigon is specialised in diseases caused by lipid imbalances, with an initial focus on rar... |
| 19.09.2018 | New venture at Sciety – wants to help researchers in the search for new treatments | Cartana is based at Karolinska Institute in Stockholm and has developed a new technology for researchers to analyse tissue samples in drug development processes. The company is ready to launch at the market for brain research and will launc... |
| 29.08.2018 | 5 common questions about investing in unlisted companies | If you’re used to buying shares on the stock market, it doesn’t have to be a big leap to invest in unlisted companies as well. At Sciety, we frequently receive questions from people who are considering making their first investment in an un... |
| 18.06.2018 | Sciety becomes a member in SwedenBIO | Sciety becomes a member in the trade association SwedenBIO that works for a strong life science sector in Sweden. The members include micro companies to big pharma but also companies that provide services in business development, IP, financ... |
| 11.04.2018 | Sciety raises 10 MSEK via its financing platform for companies in the life science sector | Sciety closes a financing round of 10 million SEK and welcomes thirty new shareholders with backgrounds in the finance and healthcare sectors. The largest investor is the investment company Linc. |
| 06.04.2017 | Major investment interest in award-wining 1928 Diagnostics | Ett trettiotal affärsänglar går in med 20 miljoner kronor i diagnostikbolaget som med sin innovativa mjukvara ska bekämpa det globala hotet från antibiotikaresistens. Investeringarna sker via Sciety som är specialiserat på tillväxtbolag ino... |
| 21.12.2016 | Sciety raises MSEK 6 for the tech company Inhalation Sciences | The investments come partly from a business angel network and a venture capital company that already owns shares in the company and partly from new financiers, each investing from some thousand SEK up to a couple of million SEK. In total, t... |
